Want to join the conversation?
Dan Leonard of Leerink Partners asks for an update about European business trends. $A SVP Pat Kaltenbach said the company has seen growth in Central Europe and weakness in Eastern Europe, mainly driven by the energy market. He added there is strength in Germany and other states around that, with academia & government flat and strong pharma growth.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.